Safety and Efficacy of AKCEA-APO(a)-1 to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose -Ranging Trial

Tsimikas, S; Karwatowska-Prokopczuk, E; Gouni-Berthold, L; Tardif, JC; Baum, SJ; Steinhagen-Thiessen, E; Shapiro, MD; Stroes, ED; Moriarty, PM; Nordestgaard, BG; Guerriero, J; Viney, NJ; O'Dea, L; Witztum, JL

CIRCULATION, 2018; 138 (25): E755

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索